Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1977-04-14
1978-09-26
Schenkman, Leonard
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
260465B, 260465D, 260553A, 260553R, 424321, 424322, 424324, A61K 31275, C07C12700
Patent
active
041171578
ABSTRACT:
Novel 1-aryl-2-amidoalkylaminoethanol derivatives, processes for their manufacture, pharmaceutical compositions containing them and methods of using them in the treatment of heart diseases. The compounds possess .beta.-adrenergic blocking activity. Representative of the compounds disclosed ia 1-phenyl-2-(1,1-dimethyl-2-phenylacetamidoethyl)aminoethanol.
REFERENCES:
patent: 3816516 (1974-06-01), Cox et al.
patent: 3928412 (1975-12-01), Smith
patent: 3944611 (1976-03-01), Smith
patent: 4034112 (1977-07-01), Smith
Imperial Chemical Industries Limited
Schenkman Leonard
LandOfFree
Ethanolamine derivatives having .beta.-adrenergic blocking activ does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ethanolamine derivatives having .beta.-adrenergic blocking activ, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ethanolamine derivatives having .beta.-adrenergic blocking activ will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2090499